INNO3MED : revenue, balance sheet and financial ratios

INNO3MED is a French company founded 13 years ago, specialized in the sector Intermédiaires spécialisés dans le commerce d'autres produits spécifiques. Based in ANDRESY (78570), this company of category PME shows in 2020 a revenue of 360 k€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-05-09

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - INNO3MED (SIREN 791101934)
Indicator 2024 2023 2020 2019 2018 2016
Revenue N/C N/C 359 749 € 559 521 € 356 836 € 204 256 €
Net income -27 613 € -3 308 € 53 097 € 65 312 € 40 823 € 38 470 €
EBITDA N/C N/C 62 764 € 71 321 € 44 490 € 43 641 €
Net margin N/C N/C 14.8% 11.7% 11.4% 18.8%

Revenue and income statement

In 2024, INNO3MED records a net loss of 28 k€. This deficit will reduce equity on the balance sheet.

Net income (2024) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

-27 613 €

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 6%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 91%. This high autonomy means the company finances most of its assets through equity, a sign of strength.

Debt ratio (2024) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

6.438%

Financial autonomy (2024) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

90.511%

Solvency indicators evolution
INNO3MED

Sector positioning

Debt ratio
6.44 2024
2020
2023
2024
Q1: 0.0
Med: 5.8
Q3: 35.12
Average +6 pts over 3 years

In 2024, the debt ratio of INNO3MED (6.44) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.

Financial autonomy
90.51% 2024
2020
2023
2024
Q1: 15.09%
Med: 44.33%
Q3: 67.75%
Excellent

In 2024, the financial autonomy of INNO3MED (90.5%) ranks in the top 25% of the sector. This ratio represents the share of equity in total financing. High autonomy reflects financial independence and ability to absorb shocks.

Repayment capacity
0.19 years 2020
2020
Q1: 0.0 years
Med: 0.0 years
Q3: 0.94 years
Average

In 2020, the repayment capacity of INNO3MED (0.19) ranks above the median of the sector. This ratio indicates the number of years needed to repay debt with cash flow. A reduction effort could improve financial strength.

Liquidity ratios

The liquidity ratio (= Current assets / Current liabilities) stands at 2729.98. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.

Liquidity ratio (2024) ?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good
1-1.5 : Fair
< 1 : Liquidity risk

2729.982

Liquidity indicators evolution
INNO3MED

Sector positioning

Liquidity ratio
2729.98 2024
2020
2023
2024
Q1: 144.96
Med: 248.4
Q3: 435.6
Excellent +19 pts over 3 years

In 2024, the liquidity ratio of INNO3MED (2729.98) ranks in the top 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio above 1 ensures comfortable coverage of short-term maturities.

Interest coverage
0.0x 2020
2020
Q1: 0.0x
Med: 0.0x
Q3: 1.23x
Average

In 2020, the interest coverage of INNO3MED (0.0x) ranks below the median of the sector. This ratio indicates how many times operating income covers interest expenses. An improvement would strengthen the competitive position.

Working capital requirement (WCR) and payment terms

Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.

Operating WCR (2024) ?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released
Positive = financing needed

0 €

Customer credit (2024) ?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good
45-60j : Average
> 60j : Long

0 j

Supplier credit (2024) ?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow

0 j

Inventory turnover (2024) ?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover

0 j

WCR and payment terms evolution
INNO3MED

Positioning of INNO3MED in its sector

Comparison with sector Intermédiaires spécialisés dans le commerce d'autres produits spécifiques

Similar companies (Intermédiaires spécialisés dans le commerce d'autres produits spécifiques)

Compare INNO3MED with other companies in the same sector:

Voir toutes les statistiques du secteur Intermédiaires spécialisés dans le commerce d'autres produits spécifiques

Frequently asked questions about INNO3MED

What is the revenue of INNO3MED ?

The revenue of INNO3MED in 2020 is 360 k€.

Is INNO3MED profitable?

INNO3MED recorded a net loss in 2024.

Where is the headquarters of INNO3MED ?

The headquarters of INNO3MED is located in ANDRESY (78570), in the department Yvelines.

Where to find the tax return of INNO3MED ?

The tax return of INNO3MED is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does INNO3MED operate?

INNO3MED operates in the sector Intermédiaires spécialisés dans le commerce d'autres produits spécifiques (NAF code 46.18Z). See the 'Sector positioning' section above to compare the company with its competitors.